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Abstract
Objective: About half of medical and health-related studies are not published. We conducted a systematic review of reports
on reasons given by investigators for not publishing their studies in peer-reviewed journals.
Methods: MEDLINE, EMBASE, PsycINFO, and SCOPUS (until 13/09/2013), and references of identified articles were searched
to identify reports of surveys that provided data on reasons given by investigators for not publishing studies. The
proportion of non-submission and reasons for non-publication was calculated using the number of unpublished studies as
the denominator. Because of heterogeneity across studies, quantitative pooling was not conducted. Exploratory subgroup
analyses were conducted.
Results:We included 54 survey reports. Data from 38 included reports were available to estimate proportions of at least one
reason given for not publishing studies. The proportion of non-submission among unpublished studies ranged from 55% to
100%, with a median of 85%. The reasons given by investigators for not publishing their studies included: lack of time or low
priority (median 33%), studies being incomplete (median 15%), study not for publication (median 14%), manuscript in
preparation or under review (median 12%), unimportant or negative result (median 12%), poor study quality or design
(median 11%), fear of rejection (median 12%), rejection by journals (median 6%), author or co-author problems (median
10%), and sponsor or funder problems (median 9%). In general, the frequency of reasons given for non-publication was not
associated with the source of unpublished studies, study design, or time when a survey was conducted.
Conclusions: Non-submission of studies for publication remains the main cause of non-publication of studies. Measures to
reduce non-publication of studies and alternative models of research dissemination need to be developed to address the
main reasons given by investigators for not publishing their studies, such as lack of time or low priority and fear of being
rejected by journals.
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Introduction
About half of medical and health related research studies
remain not published [1,2], and there is still ongoing debate about
whether publishing selectively could be justifiable [3,4]. However,
research ethical obligations require the appropriate dissemination
and publication of all research results [5]. When research methods
and results are inaccessible to users of research, the investment in
such research contributes little or nothing to knowledge or
practice. Failure to publish research can potentially be regarded
as a form of research misconduct and unethical [6]. In addition,
empirical evidence indicates the existence of research dissemina-
tion bias, as published studies tend to be systematically different
from unpublished studies [1,7]. Adverse consequences of research
inaccessibility include unnecessary duplication, harm to patients,
waste of limited resources, and loss of (trust in) scientific integrity
[1,8].
The dissemination profile of research is influenced by the
interests of a variety of different stakeholders [8]. For example,
there have been a number of high profile cases in which
unfavourable results of studies sponsored by pharmaceutical
companies were publically inaccessible for commercial reasons
[1,9]. Rejection by journals may also be a cause of non-publication
of studies. However, evidence indicates that many studies remain
unpublished because researchers failed to write up and submit
their work to journals for publication [10–12]. Researchers are
motivated to publish as many studies as possible because of a
‘‘publish or perish’’ culture [13,14]. It is therefore surprising that
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investigators who need to publish are the main cause of non-
publication of studies.
There are many recently published survey studies that have
reported reasons given by researchers describing why they failed to
publish their work in peer-reviewed journals. We conducted a
systematic review of relevant surveys, in order to improve our
understanding of reasons given by investigators for not publishing
studies, and help to develop innovative, new or better measures to
reduce non-publication of completed research.
Methods
We searched MEDLINE, EMBASE, PsycINFO, and SCOPUS
for relevant reports until 13th September 2013 (see Appendix S1
for the search strategy). References of retrieved articles and
reviews on publication bias were also examined for relevant
studies. Titles and abstracts of retrieved citations from the searches
of electronic databases were screened by two independent
reviewers. Full text articles of possibly relevant studies were
assessed by one reviewer to identify eligible studies.
We included any reports of surveys that provided data on
reasons given by investigators for not publishing studies they
conducted. Articles that discussed reasons for not publishing
studies in general but did not provide empirical data on reasons
given by investigators were excluded. There were no restrictions
on languages or publication status. We used Google Translate to
obtain key information from studies published in languages other
than English.
Data extraction was conducted by one reviewer (FS), and
checked by a second reviewer (YL or LH). From the included
survey reports, we extracted the following data: source and types of
unpublished studies (conference abstracts, study protocols, survey
of academics or professionals, postgraduate submissions, rejected
manuscripts, study sponsors, and trial registries), survey methods,
response rate, number of unpublished studies, number of
unsubmitted studies, stated reasons for not publishing.
Methods used to categorise reasons for not publishing may be
different across included surveys. Stated reasons for not publishing
were grouped into categories: including lack of time or low
priority, unimportant or negative results, journal rejection, fear of
being rejected, and so on. We used the number of unpublished
studies as the denominator to calculate the proportion of non-
submission and specific reasons for non-publication for each
included survey reports. First, proportions of reasons reported in
survey reports were transformed to normally distributed values
using the Freeman-Tukey transformation methods [15,16]. The
normally distributed transformed proportions were then used to
estimate 95% confidence intervals and for meta-regression
analyses. The use of transformed proportions for estimating
confidence intervals also avoided the possibility of inappropriate
results where the lower limit is below zero or the upper limit
exceeds one, when the point proportion is approaching 0% or
100%.
Because of significant heterogeneity across reports, quantitative
pooling of results was not conducted. We used forest plots to
visually present individual results of included reports, and
presented medians and ranges (minimum to maximum) of
reported proportions of reasons given for non-publication.
For exploratory subgroup analysis, included reports were
separated into subgroups by types of unpublished studies (abstracts
Figure 1. Flow diagram for study selections.
doi:10.1371/journal.pone.0110418.g001
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vs. protocols or other), design of unpublished studies (clinical trials
only vs. other or different designs), period of surveys conducted
(before 2000, from 2000 to 2004, and since 2005), rate of non-
submission, and response rate. The differences between subgroups
were statistically tested using univariate, random-effects meta-
regression (Stata/IC 12.1 for Windows ‘‘metareg’’ command), and
the Bonferroni correction was used for multiple statistical testing.
Results
The process of study selection is shown in Figure 1. By checking
titles and abstracts of retrieved citations (n = 6559), we identified
108 citations that were possibly relevant. After examining the 108
full-text articles, we included 53 reports that provided investiga-
tor’s reasons for not publishing their studies [10,11,17–67]. One
additional report was identified by an informal search of PubMed
[68], because the formal search excluded titles that used terms
‘‘meta-analysis’’ or ‘‘systematic review’’ (See Appendix S1). We
included 54 survey reports in total.
The main characteristics of the included reports are presented
in Appendix S2. Non-publication was generally defined as lack of
full publication in peer-reviewed journals. Of the 54 included
reports, 10 surveys were conducted before 2000, 17 conducted
from 2000 to 2004, and 27 conducted since 2005. There were 27
surveys of authors of unpublished conference abstracts, 11 reports
in which unpublished studies were revealed by academics or
professionals who responded to a survey, 7 reports in which
unpublished studies were identified from protocol cohorts, 4
surveys of postgraduate submissions, two surveys of studies
sponsored by a funding body, two surveys of rejected manuscripts,
and one survey of studies from a trial registry.
There were 38 reports that included unpublished studies with a
mix of different designs or types, 11 reports that included only
unpublished trials, and one each for unpublished animal research,
epidemiological research, qualitative research, methodological
research, and systematic reviews (Appendix S2).
Survey methods included mainly postal or email questionnaires,
and telephone or face-to-face interviewing. The response rate by
authors ranged from 8% to 100%, with a median of 64%
(Appendix S2). According to 43 reports with sufficient data, the
median number of unpublished studies was 65 (ranged from 7 to
223). Of the 54 included reports, 38 provided sufficient data to
estimate proportions of at least one stated reason.
Main reasons for non-publication
Table 1 presents the medians and ranges of reported propor-
tions of reasons for non-publication. Estimated proportions (with
95% confidence intervals) of reasons for non-publication from
individual reports and results of statistical tests for heterogeneity
are shown in Appendix S3 (forest plots).
Two reports included only studies that had been rejected for
publication by journals [35,46]. Using data from the other 30
reports, the proportion of non-submission among unpublished
studies ranged from 55% to 100%, with a median of 85% (Table 1
and Figure 2).
The most commonly stated reason for non-publication was lack
of time or low priority (median 33%, range: 11% to 60%)
(Table 1). Other important reasons for non-publication included:
studies being incomplete or still ongoing (median 15%), study not
for publication (median 14%), manuscript in preparation or under
review (median 12%), unimportant or negative result (median
12%), poor study quality or design (median 11%), fear of rejection
(median 12%), rejection by journals (median 6%), author or co-
author problem (median 10%), and sponsor or funder problem
(median 9%).
Findings from the included reports in which data were
insufficient for quantitative analyses were qualitatively consistent
with the above results. For example, lack of time was often
mentioned as an important reason for non-publication of studies
(Appendix S2).
Heterogeneity in reasons given for non-publication
There was substantial heterogeneity in the proportion of reasons
given for non-publication across individual reports (Table 1 and
Appendix S3). The results of exploratory subgroup analyses are
presented in Appendix S4. In most cases, heterogeneity across
reports could not be explained by sources of unpublished studies,
study design, period of surveys, response rate, or non-submission
rate (Appendix S4). There were four statistically significant
findings (P,0.05) out of a total of 57 statistical tests of subgroup











Non-submission 30 2156/2592 85% (55%, 100%)
Study incomplete or ongoing 18 273/1509 15% (3%, 56%)
In preparation or under review 22 293/1778 12% (3%, 65%)
Study not for publication 9 107/880 14% (3%, 38%)
Similar findings published 10 52/867 5% (3%, 13%)
Submission rejected by journal 25 210/2197 6% (2%, 27%)
Fear of being rejected 9 110/926 12% (6%, 26%)
Lack of time or low priority 32 873/2634 33% (11%, 60%)
Results not important or negative 19 293/1593 12% (1%, 34%)
Poor study quality or design 16 197/1611 11% (2%, 32%)
Sponsor/funder problems 4 31/230 9% (5%, 24%)
Author/co-author problems 14 156/1337 10% (4%, 23%)
doi:10.1371/journal.pone.0110418.t001
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differences. If a Bonferroni correction was used for multiple
statistical testing, only one of the subgroup analyses retained
statistical significance. A higher proportion of non-submission was
statistically significantly associated with a lower proportion of
journal rejection (after the Bonferroni correction, P,0.01) as a
reason for non-publication, which is expected as unsubmitted
manuscripts cannot be rejected by journals. Specifically, journal
rejection as a reason for non-publication was reduced by 0.7%,
with a 10% increase in non-submission. For the three other
subgroup analyses with P,0.05, subgroup differences became
statistically non-significant with the Bonferroni correction for
multiple testing (see Appendix S4 for details).
Discussion
Our systematic review is the most comprehensive review of
reasons given by investigators for not publishing studies. As 85% of
unpublished studies have not been submitted to journals, non-
publication of many studies was directly caused by failure of
Figure 2. Proportions of non-submission among unpublished studies – results of individual surveys.
doi:10.1371/journal.pone.0110418.g002
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authors to write up and submit their work to journals. The most
commonly stated reason for non-publication was lack of time or
low priority. Other stated reasons included unimportant or
negative result, study not completed, study not for publication,
fear of journal rejection, poor study quality or design, manuscript
in preparation or under review, author or co-author problem,
sponsor or funder problem.
Acceptability of reasons given for not publishing studies
Research dissemination will be a biased process when non-
publication is due to negative results, which is clearly unacceptable
[8]. Some of the stated reasons seem acceptable for non-
publication of a study, such as manuscript in preparation or
under review, or the study being still ongoing. However, the
acceptability of most stated reasons is disputable in terms of
potential bias in the research literature and the ethics of scientific
conduct [69,70].
Except for two reports that included only studies rejected by a
journal, journal rejection was an infrequently stated reason for
non-publication (median 6%). Rejection by a journal may not
necessarily be an acceptable reason for non-publication, as many
studies which were eventually published had previously been
rejected by one or more journals. Okike et al. found that, in five
years, 76% of the manuscripts rejected by the Journal of Bone and
Joint Surgery (American Volume) had been published in other
journals [46].
Fear of journal rejection (median 12%) was a more frequently
stated reason than the actual rejection by journals (median 6%).
Therefore, the low proportion of journal rejection as a reason for
non-publication may be partly due to the selective submission of
studies by investigators. To some extent, experienced researchers
may be able to guess whether and where a study is likely to be
accepted for publication. Fear of being rejected may originate
from perception that results are not important or statistically non-
significant, awareness of poor study quality, and similar findings
already being published by others. Brice and Chalmers found that
only 12% of high quality medical journals explicitly encourage
authors to submit manuscripts of robust research, ‘‘regardless of
the direction or strength of the results’’ [71]. Unfortunately, there
was no direct empirical evidence to reveal why authors felt their
work was unlikely to be accepted by a journal.
Lack of time or low priority (median 33%) is an arguable reason
for not publishing studies. Individual researchers may become
swamped if engaged in several streams of research that could
potentially be developed for journal publication. It is very time-
consuming to prepare, submit, revise, and re-submit manuscripts
for publication. Repeated rejection by multiple journals is not
unusual before a study is eventually accepted. For career
advancement, rewards from publishing in high-impact journals
would be greater than in low-impact journals. Many researchers
may indeed have insufficient time to publish all their work in peer-
reviewed journals. It is therefore practically logical for investigators
to focus on ‘‘wonderful results’’ rather than ‘‘negative results’’, as
the former may be more likely to be published in a high-impact
journal [20]. Fanelli found that the frequency of reporting positive
results was associated with ‘the more competitive and productive
academic environments’ in the United States [72].
It has been stated that some unpublished studies were not
intended for publishing in peer-reviewed journals (median 14%).
Postgraduate theses or dissertations are used to obtain academic
degrees or professional certificates. However, there is no good
reason not to publish degree theses [73]. Feasibility or pilot studies
aim to help investigators to develop full scale studies, and the
methods and results of such studies should be published or
publically accessible to other researchers. Findings from industry
sponsored trials are used to gain regulatory approvals of
commercial products, and such studies should be published or
publically accessible [74].
Poor study quality or design problems as a reason for non-
publication (median 11%) is also arguable. It has been suggested
that quality rather than the number of publications should be
emphasized to measure researchers’ scientific productivity [75].
However, we need to distinguish the number of studies published
and the number of studies conducted. A reduction in emphasis on
the volume of published material should not be used to justify non-
publication of studies that have been conducted [1,76]. The results
of poor quality studies may have no immediate impact on clinical
practice and health policy. However, methodological issues or
problems experienced in failed studies may inform other
investigators to avoid similar mistakes or problems [77]. It may
be difficult to publish failed studies in peer-reviewed journals, and
alternative dissemination approaches may be required. For
example, clinical trial registries may provide a conventional
platform to record the methods and results of failed trials [78].
Suppression of unfavourable results by study sponsors or
funders has always been a concern [8]. However, only four
surveys provided data on the proportion of sponsor or funder
problem as a reason for non-publication [21,34,39,68]. A survey of
study protocols with different designs, conducted in 1990, found
that 24% of the 78 unpublished studies were due to sponsor
control of data [34]. The three more recent studies reported lower
proportions of sponsor or funder problem as a reason for non-
publication (5%, 7%, and 11% respectively) [21,39,68]. Non-
publication of studies because of sponsors or funders was
considered to be rare but important in another three studies that
did not provide quantitative data [33,50,59].
Some studies were not published because other investigators
had already published similar findings (median 5%). However,
unnecessary duplication should be distinguished from appropriate
replication. Empirical evidence does reveal the existence of
unnecessary duplication in health research, and new research
should be justified according to what is already known from
systematically reviewing existing evidence [79]. However, with
regards to completed studies, results from all primary research
should be properly maintained and made publicly accessible.
Author or co-author problems were further reasons given for
not publishing studies (median 9%), including job/post change,
trouble with co-authors, and other’s responsibility to write up. It is
unclear why a higher proportion of author problems was
associated with a lower response rate, and why it was a more
frequent reason for non-publication of clinical trials compared to
non-publication of studies with mixed or other designs (Appendix
S4). It is likely that, to some extent, author problems are associated
with other stated reasons such as lack of time or low priority,
unimportant results, and poor study quality. For example, if the
principal investigator decides not to publish, it may be very
difficult for junior co-investigators to publish results, even if they
would like to [80].
Implications for strategies to reduce non-publication of
studies
Prospective registration of clinical trials at their inception has
been developed in order to reduce selective publication of trials
[8,81]. However, it is currently mandatory only for certain
categories of clinical trials (for example, trials of medicinal
products or medical device). It is still difficult, if not impossible,
to uncover unpublished observational research and basic biomed-
ical studies. In addition to prospective registration of studies and
Why Not Publishing Studies
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other enforcement measures, additional measures are required,
relating to the main reasons given by investigators for not
publishing their studies.
Existing recommendations for reducing non-publication of
studies may have failed to give sufficient consideration to
commonly stated reasons, such as lack of time or low priority,
by investigators for not publishing studies. For instance, the
problem of lack of time needs to be addressed from the beginning
to the end of a research. First, as Altman recommended, we need
‘‘less research, better research, and research done for the right
reasons’’ [82]. Any new research should be relevant and of
sufficiently high quality [79]. If national registries of funded
projects (across funding bodies) were made available, research
funders would be able to take into account the recent and current
workload of investigators, so that they won’t simultaneously
conduct too many studies. Moreover, researchers who failed to
publish findings from their completed studies could be given lower
priority for further funding, preferably across funding bodies. The
publication rate of funded studies from the Health Technology
Assessment (HTA) Programme in the UK was 98% after 2002, by
publishing the results in the programme’s own journal (HTA
monograph) and withholding 10% of funds until the publication of
the full report [83].
Second, the process of peer-reviewed publications should be
more streamlined, and modified to save investigators’, peer-
reviewers, and editors’ time [84]. It would save time if the same
general guidelines for manuscript submission could be adopted by
different journals. Many studies are rejected by multiple journals
before they are eventually accepted for publication. Effort and
time required to publish studies that are likely to be rejected by
multiple journals will be particularly great, because the format of a
manuscript needs to be changed before submitting it to each
different journal, and repeated editorial and peer-review processes
by different journals are required for a single manuscript.
For some studies, publication in a conventional journal may be
too time-consuming to pursue, or the possibility of being accepted
by a journal is extremely slim for various reasons. Therefore, there
is a need for alternative modalities to retain ‘‘unpublishable’’
studies so that other researchers could easily identify these studies
and access their methods and results. Investigators should need
much less time to publish their work by alternative approaches
than in conventional journals. The publication of studies through
the alternative system should be acceptable as the fulfilment of
mandatory research dissemination required by research sponsors,
funders, and other regulatory bodies. Given advanced information
technology, the development of publication processes alternative
to conventional journals is technically possible. For example,
established trial registration system can be alternative models for
research dissemination, whereby results can be posted together
with previously registered protocols [84]. Other models for
scientific communication have also been tested in some research
fields [85,86].
Limitations of the review
Biased selection of studies for publication may be a common
problem in any research fields. However, it is unclear whether the
results of this systematic review are directly relevant to the non-
publication of research in fields other than medical and health-
related studies. Reasons for non-publication of studies may even
be different within medical and health-research. Further research
is required to examine the similarity and differences in research
dissemination of different fields.
The quality of the included surveys was not formally assessed, as
we are not aware of any validated tools to assess quality of such
studies. One readily available indicator of survey quality may be
the response rate by authors, which ranged from 8% to 100%
(median 64%). Publication bias and outcome reporting bias is
likely in the included studies. The estimated frequency of stated
reasons may be exaggerated when multiple reasons reported by a
small number of respondents in some surveys were lumped
together into a single ‘‘other’’ category, which could not be used
for calculating proportions. Multiple reasons for non-publication
of individual studies were usually allowed in included surveys, so it
is possible that the frequency of some stated reasons may have
been under-estimated when investigators partially selected reasons
that were interrelated. In addition, we were unable to distinguish
between one-off rejections as compared to repeated rejections by
journals.
This systematic review included very diverse studies in terms of
sources of unpublished studies, types of unpublished studies,
research fields, survey methods, selection of survey participants,
and questions asked about reasons for not publishing studies.
Although the generalizability of findings from this systematic
review may be improved by including diverse reports, there was
significant heterogeneity in results across the included reports. In
general, the frequency of main reasons given for non-publication
was not associated with the source of unpublished studies, study
design, response rate, or time when a survey was conducted. Three
of the four significant subgroup differences (at the level of P,
0.05), from a large number of subgroup analyses, were no longer
statistically significant if the Bonferroni correction was carried out.
In most cases, the differences between subgroups were small and
with unclear practical importance. In addition, the power of meta-
regression analyses was limited due to the relatively small number
of primary studies included. Therefore, results of our subgroup
analyses should be interpreted with great caution [87].
Conclusions
Non-submission of studies for publication remains the main
cause of non-publication of medical and health-related studies.
Measures to reduce non-publication of studies and alternative
models of research dissemination need to be developed taking into
account the common reasons given by investigators for not
publishing their studies, such as lack of time or low priority and
fear of being rejected by journals.
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